Table 3 Comparison of respiratory assessment parameters between patients with and without insomnia
Patients with insomnia (ISI score > 7) (n = 12) | Patients without insomnia (ISI score ≤ 7) (n = 16) | p | |
|---|---|---|---|
CASA-Q score | 51 (35–70) | 34 (29–40) | < 0.05 |
Nocturnal cough | 7 (58%) | 6 (38%) | 1.00 |
mMRC score | |||
≥ 1 | 7 (58%) | 8 (50%) | 0.72 |
≥ 2 | 5 (42%) | 0 (0%) | < 0.05 |
Nasal obstruction | 6 (50%) | 2 (13%) | 0.09 |
Pulmonary exacerbations | 1 (0–2) | 1 (0–2) | 0.64 |
Number per year | |||
Number over last 3 months | 1 (0–1) | 0 (0–1) | 0.78 |
At least 1 exacerbation in the past year | 6 (50%) | 10 (62%) | 0.70 |
At least 1 exacerbation in the past 3 months | 6 (50%) | 7 (44%) | 1.00 |
At least 1 antibiotic use in the past year | 4 (33%) | 2 (13%) | 0.35 |
Bacterial colonization of the airways (n = 27) | |||
Pseudomonas aeruginosa | 3 (25%) | 11(69%) | 0.24 |
Burkholderia cepacia | 0 (0%) | 0 (0%) | 1.00 |
Stenotrophomonas maltophilia | 1 (8%) | 0 (0%) | 0.44 |
Achromobacter xylosoxidans | 0 (0%) | 0 (0%) | 1.00 |
Pulmonary function tests | |||
FEV1 (mL) | 2885 (1470–3490) | 2065 (1540–4030) | 0.93 |
FEV1 (% predicted) | 74 (40–108) | 66 (38–89) | 0.42 |
FVC (mL) | 3945 (2720–4435) | 3530 (2680–5100) | 1.00 |
FVC (% predicted) | 97 (65–113) | 86 (65–97) | 0.22 |
FEV1/FVC | 64 (55–82) | 69 (53–74) | 0.70 |
6 MWT (n = 16) | |||
SpO2 min (%) | 93 (91–96) | 96 (93–97) | 0.25 |
Distance (m) | 496 (425–584) | 581 (505–630) | 0.21 |